BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Division of Gastroenterology//NONSGML Events//EN
CALSCALE:GREGORIAN
X-ORIGINAL-URL:https://gastro.wustl.edu/events/
X-WR-CALDESC:Division of Gastroenterology - Events
BEGIN:VEVENT
UID:20220408T1500Z-1649430013.4771-EO-8120-1@172.23.128.18
STATUS:CONFIRMED
DTSTAMP:20260517T015317Z
CREATED:20220408T145333Z
LAST-MODIFIED:20220408T150749Z
DTSTART;TZID=America/Chicago:20220412T070000
DTEND;TZID=America/Chicago:20220412T080000
SUMMARY: Journal Club
DESCRIPTION: Speakers: GI Fellows: Suha Abushamma\, MBBS – “Self-expandable
  metal stents versus endoscopic balloon dilation for the treatment of stric
 tures in Crohn’s disease (ProtDilat study): an open-label\, multicentre\, r
 andomised trial” Siyan “Stewart” Cao\, MD\, PhD – “Eflornithine plus Sulind
 ac for Prevention of Progression in Familial Adenomatous Polyposis” Please 
 Contact Beth Buschard-Steiger (bbuscha@wustl.edu) for Zoom Details
X-ALT-DESC;FMTTYPE=text/html: <h2 style="text-align: center\;">Speakers:</h
 2><h3 style="text-align: center\;">GI Fellows:</h3><h4 style="text-align: c
 enter\;">Suha Abushamma\, MBBS - <em>"Self-expandable metal stents versus e
 ndoscopic balloon dilation for the treatment of strictures in Crohn's disea
 se (ProtDilat study): an open-label\, multicentre\, randomised trial"</em><
 /h4><h4 style="text-align: center\;">Siyan "Stewart" Cao\, MD\, PhD - <em>"
 Eflornithine plus Sulindac for Prevention of Progression in Familial Adenom
 atous Polyposis"</em></h4><p style="text-align: center\;">Please Contact Be
 th Buschard-Steiger (<a href="mailto:bbuscha@wustl.edu">bbuscha@wustl.edu</
 a>) for Zoom Details</p>
CATEGORIES:Journal Club
LOCATION:Zoom
GEO:38.635144;-90.262929
ORGANIZER;CN="Leslie":MAILTO:larnold@wustl.edu
URL;VALUE=URI:https://gastro.wustl.edu/events/event/journal-club-3/
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
DTSTART:20220313T080000
TZNAME:CDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR
